|
Why do so many drugs for Alzheimer's disease fail in development? Time for new m...
Alzheimer's disease (AD) drug developments and clinical trials (CT) remain vulnerable to problems that undermine research validity. Investigations of CT methods reveal how numerous factors decrease ac READ MORE
http://www.ncbi.nlm.nih.gov/pubmed/18953116
|